| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| May 13, 2026 | ±2.4% | +1.1% | over-priced |
| November 12, 2025 | ±2.4% | +3.0% | under-priced |
| May 14, 2025 | ±3.2% | -1.6% | over-priced |
| November 6, 2024 | ±2.5% | +16.0% | under-priced |
| August 7, 2024 | ±4.3% | -3.2% | over-priced |
| May 8, 2024 | ±2.2% | -1.2% | over-priced |
| November 8, 2023 | ±2.1% | +1.0% | over-priced |
| August 9, 2023 | ±2.8% | -0.3% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $3.23 | $9.5B | $870M |
| Q4 FY2025 | $1.64 | $7.7B | $423M |
| Q3 FY2025 | $2.63 | $8.5B | $683M |
| Q1 FY2025 | $0.67 | $7.8B | $226M |
Nucor Corporation (NUE) reports in 130 days, with the next report estimated for October 21, 2026. Across the last 8 reports, options priced an average ±2.7% earnings move while the stock actually moved 3.4% on average — the market has systematically over-priced NUE's earnings risk. Fundamentals into the print: EPS up 164.8% year-over-year, revenue up 34.2%. QuantLogix's live 5-factor engine currently reads NUE as a buy at 55/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →